Nipah Virus Infection
On this page
Direct answer
Fever with rapidly progressive encephalopathy, segmental myoclonus, brainstem signs and cough or breathlessness in a person from a Nipah-affected belt of Kerala or West Bengal is Nipah virus infection until excluded — a henipavirus carried by Pteropus fruit bats, with case fatality historically between 40 and 70 per cent in Indian outbreaks. There is no proven antiviral; care is supportive with aggressive infection control, since human-to-human transmission within families and hospitals is a defining feature of the Bangladesh-genotype strain circulating in India. Diagnosis is by RT-PCR on throat swab, urine or blood and IgM ELISA during convalescence, with NIV Pune as the reference laboratory, and Kerala's recurrent outbreaks since 2018 have made contact tracing and quarantine the examinable public-health answer.
What you must remember
- Agent and reservoir: Nipah virus, a Paramyxoviridae henipavirus; reservoir is the Pteropus fruit bat (flying fox), with intermittent spillover to humans — directly from bats (date-palm sap contamination in Bangladesh) or via intermediate hosts such as pigs in the Malaysian outbreak of 1998-99.
- Indian strain: the Bangladesh genotype circulating in Kerala and West Bengal transmits person to person more readily than the Malaysian genotype — the reason barrier nursing and contact precautions are central.
- Clinical signature: incubation about 4-14 days (up to 21 documented); fever and headache progressing to encephalitis with altered sensorium, segmental myoclonus (a near-pathognomonic exam feature), seizures, brainstem signs and autonomic instability such as hypertension and tachycardia; a respiratory syndrome with cough and atypical pneumonia to ARDS accompanies or precedes neurological illness in many.
- Diagnosis: RT-PCR on throat or nasopharyngeal swab, urine, blood or cerebrospinal fluid during illness; IgM and IgG ELISA in later samples; NIV Pune confirms — and "send samples to NIV Pune" is a legitimate exam answer.
- Treatment: none proven — supportive intensive care; ribavirin was used in the Malaysian outbreak with possible but unproven benefit; the monoclonal antibody m102.4 has been procured by ICMR for potential compassionate use, and a vaccine remains in development.
- Infection control: isolate suspected cases, full PPE for contacts of body fluids, restriction of close family contact with the critically ill, and 21-day quarantine of contacts — Kerala's containment playbook.
- Epidemiology in India: Siliguri (2001), Nadia (2007), then Kerala's Kozhikode outbreaks from 2018 onwards with recurrent episodes in 2019, 2021, 2023 and 2024 — each small, each with high fatality, each terminated by aggressive tracing; avoid date-palm sap and raw sap products where relevant, and avoid contact with sick bats or pigs.
- Differential at the bedside: Japanese encephalitis (seasonal, paediatric preponderance, extrapyramidal features more than myoclonus), cerebral malaria (smear-positive), and scrub typhus meningoencephalitis (eschar, doxycycline response).
How an outbreak response is walked through
A man from Kozhikode presents with four days of fever and cough, then drowsiness with jerking of one arm; two family members had a similar fatal illness the previous week. Step one is to think Nipah immediately in this geography and cluster — the combination of encephalitis with segmental myoclonus, respiratory involvement and a sick-family history is the recognisable gestalt, and the first clinical act is isolation with PPE before any diagnostic waiting. Step two is notification and sampling: throat swab, urine and blood for RT-PCR to NIV Pune, plus malaria smear and scrub typhus serology to close the treatable differentials in parallel rather than sequentially. Step three is supportive intensive care — airway protection for depressed consciousness, management of seizures and autonomic storms, lung-protective ventilation for ARDS — with honest counselling that mortality is high and that no proven antiviral exists; ribavirin and m102.4 are decisions for the outbreak response team, not ward improvisation. Step four is the containment ring: list every contact from symptom onset onwards, home-quarantine them for 21 days with daily symptom monitoring, test any who develop fever, and protect healthcare workers with full PPE and buddy-checking — hospital amplification was the defining tragedy of Siliguri. Step five is the source investigation — bat activity around the household, consumption of contaminated fruits or sap, and community messaging about avoiding raw sap and half-eaten fruits — closing the loop that Kerala has executed successfully in every recurrence since 2018.
Where students slip
The first slip is the differential reflex: in any Indian encephalitis, candidates answer Japanese encephalitis automatically; a stem that adds segmental myoclonus, respiratory illness, a Kerala address and a sick contact is asking for Nipah, and the word "myoclonus" is doing the heavy lifting. The second is transmission: students quote pigs and horses from the Malaysian narrative, whereas Indian (Bangladesh-genotype) transmission is bat-to-human via contaminated sap or fruits and, critically, human-to-human in families and hospitals. Third, treatment answers drift into antivirals; the expected answer is supportive care with rigorous infection control, with ribavirin and the ICMR-held monoclonal as hedged experimental options. A quiet viva favourite is why Nipah is a WHO priority pathogen — high case fatality, no licensed human vaccine, and epidemic potential in a densely populated region.
Frequently asked questions
What clinical feature of Nipah encephalitis is most characteristic?
Segmental myoclonus accompanying altered sensorium, with brainstem signs and autonomic instability, often preceded or accompanied by cough and atypical pneumonia in the Bangladesh-genotype illness seen in India.
How is Nipah virus transmitted in India?
From Pteropus fruit bats to humans through contaminated date-palm sap or fruits, and then person to person via respiratory droplets and close contact with body fluids — the pattern that made family and hospital clusters the hallmark of Kerala outbreaks.
What samples diagnose Nipah and where are they tested?
RT-PCR on throat or nasopharyngeal swab, urine, blood or CSF during illness, with IgM and IgG ELISA on convalescent samples, confirmed at the National Institute of Virology, Pune.
Is there any specific treatment for Nipah virus infection?
No proven antiviral exists; management is supportive intensive care with strict infection control, while ribavirin has possible historical benefit and the m102.4 monoclonal antibody is held by ICMR for potential compassionate use.
Which Indian states have experienced Nipah outbreaks?
West Bengal (Siliguri 2001, Nadia 2007) and Kerala, with recurrent Kozhikode and Malappuram episodes from 2018 through 2024, each contained through contact tracing, quarantine and barrier nursing.